The role of N-glycans in colorectal cancer progression: potential biomarkers and therapeutic applications

Julio Cesar Madureira de Freitas Junior _ and José Andrés Morgado-Díaz

PDF  |  HTML  |  How to cite

Oncotarget. 2016; 7:19395-19413. https://doi.org/10.18632/oncotarget.6283

Metrics: PDF 4739 views  |   HTML 4376 views  |   ?  


Julio Cesar Madureira de Freitas Junior1 and José Andrés Morgado-Díaz1

1 Cellular Biology Program, Structural Biology Group, Brazilian National Cancer Institute (INCA), Rio de Janeiro, RJ, Brazil

Correspondence to:

Julio Cesar Madureira de Freitas Junior, email:

José Andrés Morgado-Díaz, email:

Keywords: N-glycans, colorectal cancer, biomarkers, glycosylation, carcinoma

Received: May 28, 2015 Accepted: October 22, 2015 Published: November 02, 2015


Changes in glycosylation, which is one of the most common protein post-translational modifications, are considered to be a hallmark of cancer. N-glycans can modulate cell migration, cell-cell adhesion, cell signaling, growth and metastasis. The colorectal cancer (CRC) is a leading cause of cancer-related mortality and the correlation between CRC progression and changes in the pattern of expression of N-glycans is being considered in the search for new biomarkers. Here, we review the role of N-glycans in CRC cell biology. The perspectives on emerging N-glycan-related anticancer therapies, along with new insights and challenges, are also discussed.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 6283